Source: GlobeNewswire

Press Release: Zosano Pharma : Zosano Pharma to Host Conference Call on Second Quarter 2017 Financial Results and Provide Operational Update

FREMONT, Calif., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical stage biopharmaceutical company focused on providing systemic administration of therapeutics to patients using our proprietary Adhesive Dermally-Applied Microarray (ADAM) technology, today announced that it will host a conference call and webcast to be held on Thursday, August 10, 2017 at 4:30PM ET. At this time, management will discuss results for the second quarter of 2017 and provide an operational update for the remainder of the year. The Company will announce its financial results for this period in a press release to be issued prior to the call.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Steven Lo's photo - President & CEO of Zosano Pharma

President & CEO

Steven Lo

CEO Approval Rating


Zosano Pharma is a clinical-stage biopharmaceutical company that researches, develops and commercializes novel therapeutics to treat migraines. Read more